Genprex, Inc. Common Stock(GNPX)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$0.39
52-Week Range
$0.62 – $55.00
YTD
-78.49%
IV Rank (30D)
0
Straddle Price
$2.50
P/C Vol Ratio
0.00
Market Cap
$0.0B
Fair Value
+50.0% vs price
Confidence: 35% Alpha Score: 9.19

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.53%
Beta vs SPY1.00
Cost of Equity (CAPM)9.53%
WACC9.51%
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-98.8%
Book / Price1126.6% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$0.96 (Market Anchor value)
SMA 20 / Bollinger Mid$0.75
Bollinger Width / SMA204733.0% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABT, PFE, REGN, TEVA (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$4.21
Current Price
$0.64
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 22.1× · 4 peers
Peer EV/EBITDA n/a 0% median 12.8× · 4 peers
Peer P/B $18.37 19% median 2.5× · 4 peers
Peer P/S n/a 0% median 2.9× · 4 peers
Market Anchor (SMA50) $0.96 81% stability 85% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-12 · updated 2026-06-12 20:59:55.687000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.0B

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), i…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +64.71% 8
Feb +3.35% 8
Mar -16.28% 9
Apr +12.34% 9
May +2.94% 9
Jun -16.00% 9
Jul -14.52% 8
Aug -14.21% 8
Sep -17.06% 8
Oct +45.36% 8
Nov -23.85% 8
Dec -7.14% 8
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $0.74
SMA 50: $0.94
SMA 200: $4.21
Current: $0.64
EMA 12: $0.69
EMA 26: $0.79
MACD: -0.0930 | Signal: 0.0069
BEARISH
ADX (14): 46.08
STRONG TREND
+DI: 11.32
−DI: 31.15
Momentum Oscillators
RSI (14): 26.39
OVERSOLD
Stoch %K: 7.16
Stoch %D: 8.82
Williams %R: -91.83
Volume & Volatility
BB Upper: $0.87
BB Lower: $0.61
NEUTRAL
OBV: 14,703,718
Vol SMA 20: 235,171
Vol ROC: -32.13%
ATR: $0.05
True Range: $0.06
HV 20: 48.2%
HV 30: 48.0%
HV 60: 69.6%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:08.604000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
IV Rank (30D)
0
IV Rank (7D)
0
Avg IV
0.0%
Straddle (30D)
$2.50
Straddle (7D)
$2.50
P/C Volume
0.00
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.38
Correlation (SPY)
10.8%
0.01
Ann. Volatility
272.1%
SPY Volatility
12.3%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 2,299,277 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

27 filers87,534 shares$145.21K value3.81% of float
# Filer Shares Value % of Total % of Float Period
1 GEODE CAPITAL MANAGEMENT, LLC Custodian 33,372 $60.40K 41.60% 1.45% 2026-03-31
2 MANCHESTER FINANCIAL INC 20,000 $36.20K 24.93% 0.87% 2026-03-31
3 Mayflower Financial Advisors, LLC 20,000 $36.20K 24.93% 0.87% 2026-03-31
4 JONES FINANCIAL COMPANIES LLLP Custodian 2,105 $3.83K 2.64% 0.09% 2026-03-31
5 CITIGROUP INC Custodian 2,039 $3.69K 2.54% 0.09% 2026-03-31
6 Cheviot Value Management, LLC 1,000 $1.81K 1.25% 0.04% 2026-03-31
7 Sound Income Strategies, LLC 1,000 $1.58K 1.09% 0.04% 2026-03-31
8 OSAIC HOLDINGS, INC. Custodian 232 $417 0.29% 0.01% 2026-03-31
9 Bernard Wealth Management Corp. 200 $362 0.25% <0.01% 2026-03-31
10 BlackRock, Inc. Custodian 188 $340 0.23% <0.01% 2026-03-31
11 HARBOUR INVESTMENTS, INC. 120 $218 0.15% <0.01% 2026-03-31
12 SBI Securities Co., Ltd. 48 $87 0.06% <0.01% 2026-03-31
13 HighMark Wealth Management LLC 10 $18 0.01% <0.01% 2026-03-31
14 MORGAN STANLEY Custodian 6 $11 <0.01% <0.01% 2025-12-31
15 FNY Investment Advisers, LLC 5,000 $9 <0.01% 0.22% 2026-03-31
16 Nemes Rush Group LLC 5 $9 <0.01% <0.01% 2026-03-31
17 Allworth Financial LP Custodian 3 $6 <0.01% <0.01% 2026-03-31
18 JPMORGAN CHASE & CO Custodian 2 $4 <0.01% <0.01% 2026-03-31
19 Caitong International Asset Management Co., Ltd 2 $4 <0.01% <0.01% 2026-03-31
20 Cygnus Capital Advisors, LLC 2,195 $4 <0.01% 0.10% 2026-03-31
21 GROUP ONE TRADING LLC Custodian 1 $2 <0.01% 0.00% 2026-03-31
22 Global Retirement Partners, LLC 1 $2 <0.01% 0.00% 2025-12-31
23 UBS Group AG Custodian 1 $2 <0.01% 0.00% 2026-03-31
24 Bogart Wealth, LLC 1 $2 <0.01% 0.00% 2026-03-31
25 CURIO WEALTH, LLC 1 $2 <0.01% 0.00% 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2026-04-15
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-04-15 BRENT M LONGNECKER Director Sell (S) −18 $1.23 -$22 EDGAR
2026-02-27 Mark Stanley Berger Chief Medical Officer Tax (F) −7,168 $2.00 -$14.3K EDGAR
2026-02-27 Ryan M. Confer President, CEO and CFO Tax (F) −9,330 $2.00 -$18.7K EDGAR
2025-12-23 BRENT M LONGNECKER Director Award (A) +9,000 EDGAR
2025-12-23 William R Jr. Wilson Director Award (A) +9,000 EDGAR
2025-12-23 Toscano Jose Antonio Moreno Director Award (A) +9,000 EDGAR
2025-12-23 Mark Stanley Berger Chief Medical Officer Award (A) +28,500 EDGAR
2025-12-23 Ryan M. Confer President, CEO and CFO Award (A) +45,000 EDGAR
2025-07-01 Mark Stanley Berger Chief Medical Officer Tax (F) −4,500 $0.23 -$1.0K EDGAR
2025-07-01 Ryan M. Confer President, CEO and CFO Tax (F) −5,775 $0.23 -$1.3K EDGAR
2025-02-19 Mark Stanley Berger Chief Medical Officer Tax (F) −585 $0.41 -$240 EDGAR
2025-02-19 Ryan M. Confer President, CEO and CFO Tax (F) −395 $0.41 -$162 EDGAR
2024-12-06 Ryan M. Confer President, CEO and CFO Award (A) +29,375 EDGAR
2024-12-06 Mark Stanley Berger Chief Medical Officer Award (A) +18,250 EDGAR
2024-12-06 William R Jr. Wilson Director Award (A) +4,750 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
9 insiders · @ $0.64
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 CATHERINE M VACZY EVP GC Chief Strategy Officer 265,000 $169.7K $21.5K 4 2023-04-24
2 Hermant Kumar Chief Mfgr & Tech Officer 200,000 $128.0K $0 4 2023-02-22
3 Ryan M. Confer President, CEO and CFO 36,331 $23.3K $0 13 2026-02-27
4 John Rodney Varner Chairman, President and CEO 26,872 $17.2K $71.6K 10 2024-02-21
5 Mark Stanley Berger Chief Medical Officer 21,692 $13.9K $0 9 2026-02-27
6 BRENT M LONGNECKER Director 9,157 $5.9K $62.2K 8 2026-04-15
7 Toscano Jose Antonio Moreno Director 9,157 $5.9K $0 6 2025-12-23
8 William R Jr. Wilson Director 9,157 $5.9K $0 6 2025-12-23
9 Julien L Pham President & COO 500 $320 $1.7K 3 2019-01-29
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio0.4
EV/EBITDA0.7
TTM Net Income$-0.0B
TTM EPS$-8.54
ROE-98.8%